Irem Dogan Turacli

Dr. Irem Dogan Turacli

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Biochimie
Verified
Journal Article
Closed access
ITIrem Dogan Turacli
Irem Dogan Turacli
TCTuba Candar
Tuba Candar
EYEmine Berrin Yuksel
Emine Berrin Yuksel
SKSebnem Kalay
Sebnem Kalay
AOAli Kemal Oguz
Ali Kemal Oguz
SDSelda Demirtas
Selda Demirtas

29 March 2014 in Lung Cancer
Verified
Journal Article
Closed access
PDF file
ITIrem Dogan Turacli
Irem Dogan Turacli
SKShigeru Kawabata
Shigeru Kawabata
EBEmily Bergbower
Emily Bergbower
JGJoell J. Gills
Joell J. Gills
AEAbdullah Ekmekci
Abdullah Ekmekci
PDPhillip A. Dennis
Phillip A. Dennis

25 June 2015 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
ITIrem Dogan Turacli
Irem Dogan Turacli
AOAyla Cihan Ozkan
Ayla Cihan Ozkan
AEAbdullah Ekmekci
Abdullah Ekmekci

14 October 2018 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
ITIrem Dogan Turacli
Irem Dogan Turacli
FKFUNDA DEMIRTAS KORKMAZ
FUNDA DEMIRTAS KORKMAZ
TCTuba Candar
Tuba Candar
AEAbdullah Ekmekci
Abdullah Ekmekci

12 September 2022 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
FKFUNDA DEMIRTAS KORKMAZ
FUNDA DEMIRTAS KORKMAZ
ITIrem Dogan Turacli
Irem Dogan Turacli
GEGuldal Esendagli
Guldal Esendagli
AEAbdullah Ekmekci
Abdullah Ekmekci

29 November 2017 in Human & Experimental Toxicology
Verified
Journal Article
Closed access
ITIrem Dogan Turacli
Irem Dogan Turacli
TCTuba Candar
Tuba Candar
BYBerrin Emine Yuksel
Berrin Emine Yuksel
SDSelda Demirtas
Selda Demirtas
The antidiabetic agent metformin was shown to further possess chemopreventive and chemotherapeutic effects against cancer. Despite the advances, the underlying molecular mechanisms involved in decreasing tumor formation are still unclear. The understanding of the participation of oxidative stress in the action mechanism of metformin and its related effects on p53 and on DNA base excision repair (BER) system can help us to get closer to solve metformin puzzle in cancer. We investigated the effects of metformin in HepG2 and H2009 cells, verifying cytotoxicity, oxidative stress, antioxidant status, and DNA BER system. Our results showed metformin induced oxidative stress and reduced antioxidant capacity. Also, metformin treatment with hydrogen peroxide (H2O2) enhanced these effects. Although DNA BER enzyme activities were not changed accordantly together by metformin as a single agent or in combination with H2O2, activated p53 was decreased with increased oxidative stress in H2009 cells. Our study on the relationship between metformin/reactive oxygen species and DNA BER system in cancer cells would be helpful to understand the anticancer effects of metformin through cellular signal transduction pathways. These findings can be a model of the changes on oxidative stress that reflects p53’s regulatory role on DNA repair systems in cancer for the future studies.